HANNA DENNIS: Open Payments
NPI 1831406883 · HOLLYWOOD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 41 payments from 13 companies in 2025. Trend: 2023 $623 · 2024 $1,009 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $226 |
| Corcept Therapeutics | 6 | $142 |
| Lilly USA, LLC | 5 | $116 |
| PFIZER INC. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $18 |
| Amgen Inc. | 1 | $18 |
Products named: VRAYLAR, Korlym, MOUNJARO, NURTEC ODT, VOQUEZNA, UBRELVY, JARDIANCE, AIRSUPRA.
Industry payments across MD — which companies pay providers there.
